Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Доступна с:

Hospira Australia Pty Ltd

ИНН (Международная Имя):

Vinorelbine tartrate

Фармацевтическая форма:

Injection

состав:

Excipient Ingredients: water for injections

Администрация маршрут:

Intravenous

Штук в упаковке:

1 X 5 mL

класс:

Medicine Listed (Export Only)

Тип рецепта:

Not scheduled. Not considered by committee

Терапевтические показания :

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.

Обзор продуктов:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2008-05-21